Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DHR vs GSK✓SelectedUSD · GSKDHR vs GSK performance historyLatest closeAs of-3.16%11/20
Stock and ETF performance explorer

DHR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-18.7%
GSK return
+40.7%
Excess return
-59.4%
Maximum drawdown
-43.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.2%-0.1%-3.0%-3.1%
7D-5.4%-5.3%-0.1%-3.7%
30D-5.8%-3.7%-2.1%-4.7%
3M+2.2%-7.3%+9.5%+4.6%
6M+29.3%-4.2%+33.5%+30.5%
YTD-3.2%+0.9%-4.0%-4.5%
1Y-0.1%+7.3%-7.4%-3.6%
3Y+6.3%+52.7%-46.5%-10.4%
All-18.7%+40.7%-59.4%-32.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling